OUR PROGRAM

(주)퓨전바이오텍이 개발하고 있는 후보약물에 대해서 안내드립니다.

OUR PROGRAM

(주)퓨전바이오텍의 프로그램에 대해서 안내드립니다.

SENOLYTICS

CANDIDATE
FORMAT
INDICATION
RESEARCH
LEAD OPTIMIZATION
IND-ENABLING
CLINICAL DEVELOPMENT
FBT-NuNi
 MDM2 inhibitor
(small molecule)
Dry AMD



FBT-SP101

ROS inducer

(small molecule)

Multiple diseases




FBT-SP201

ROS inducer

(small molecule)

Multiple diseases








FUSION PROTEIN THERAPETUTICS

CANDIDATE
FORMAT
INDICATION
RESEARCH
LEAD OPTIMIZATION
IND-ENABLING
CLINICAL DEVELOPMENT
FBT-VR(HR)

VEGFR2 targeting  

recombinant protein-prolonged

Wet AMD



NANNOTHERAPEUTICS

CANDIDATE
FORMAT
INDICATION
RESEARCH
LEAD OPTIMIZATION
IND-ENABLING
CLINICAL DEVELOPMENT
FBT-HR2-ProNP
 (Recombinant protein + chemical combined)
Cancer



FBT-ER-ProNP

(Recombinant protein + chemical combined)

Cancer




ADDRESS

(주)퓨전바이오텍 Fusion Biotechnology 
대표자명 : 김채규
OFFICE : 
(44019) 울산광역시 울주군 언양읍 유니스트길 50 108동 904호

CONTACT

TEL : 010-3040-3422
FAX : 052-217-2279
MAIL : ir.fusionbiotechnology@gmail.com

ⓒ fusionbiotechnology All Rights Reserved. 2019